Metabolomics, Microbiomics, Machine learning during the COVID-19 pandemic
- PMID: 35080309
- PMCID: PMC9303466
- DOI: 10.1111/pai.13640
Metabolomics, Microbiomics, Machine learning during the COVID-19 pandemic
Abstract
COVID-19 pandemic has a significant impact worldwide, from the point of view of public health, social, and economic aspects. The correct strategies of diagnosis and global management are still under debate. In the next future, we firmly believe that combining the so-called 3 M's (metabolomics, microbiomics, and machine learning [artificial intelligence]) will be the optimal, accurate tool for the early diagnosis of COVID-19 subjects, risk assessment and stratification, patient management, and decision-making. If the currently available preliminary data obtain further confirms, through future studies on larger samples, simple biomarkers will provide predictive models for data analysis and interpretation, allowing a step toward personalized holistic medicine.
Keywords: OMICS technologies; SARS-CoV-2; biomarkers; machine learning; viral spread.
© 2022 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
-
- Hawgood S, Hook‐Barnard IG, O’Brien TC, et al. Precision medicine: Beyond the inflection point. Sci Transl Med. 2015;7:300. - PubMed
-
- Fanos V, Pintus R, Pintus MC, et al. Seven secrets of COVID‐19: fever, ACE2 receptors, gut‐lung axis, metabolomics, microbiomics, probiotics, diet. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM). 2021;10:e100145.
-
- Mussap M, Fanos V. Could metabolomics drive the fate of COVID‐19 pandemic? A narrative review on lights and shadows. Clinical Chemistry and Laboratory Medicine (CCLM). 2021;submitted. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous